Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial

Sujay A. Vora, Deanna Pafundi, Molly M. Voss, Matthew Buras, Jonathan B. Ashman, Bernard R. Bendok, William G. Breen, Leland Hu, Sani H. Kizilbash, Nadia N. Laack, Wei Liu, Anita Mahajan, Maciej M. Mrugała, Alyx B. Porter, Michael W. Ruff, Terence T. Sio, Joon H. Uhm, Ming Yang, Debra H. Brinkmann, Paul D. Brown